Kinga A.
- Country
- Poland
- Department
- 40757: Dermatology
Research Overview
- JNJ-95597528 for Moderate to Severe Atopic Dermatitis in Adults: A Phase 2b Randomized, Double-blind, Placebo-controlled Dose-ranging Study
- A Phase 1 Study of Afimkibart Effects on Cytochrome P450-Mediated Drug Metabolism in Patients With Active Ulcerative Colitis
- INCB 18424-320: A phase 3, double-blind, randomised, vehicle-controlled, efficacy and safety study of ruxolitinib cream in participants with Prurigo Nodularis. Topical ruxolitinib evaluation in Prurigo Nodularis (TRuE-PN2)
Data & Insights
Has run more than one trial at 250 of 494 partner sites.
Specializations
Dermatological Conditions
The investigator specializes in various dermatological disorders, with particular emphasis on moderate to severe plaque psoriasis and its variations across different patient populations.
- Standard plaque psoriasis management
- Special area psoriasis treatment
- Weight-dependent therapeutic approaches
Their research extends to examining long-term safety and efficacy outcomes in psoriasis treatment.
Associated Conditions
The investigator's expertise encompasses related inflammatory conditions, including psoriatic arthritis and prurigo nodularis.
- Concurrent psoriasis and arthritis management
- Inflammatory skin conditions
- Biomarker evaluation
Their work includes investigation of novel therapeutic approaches for these complex conditions.
Additional Therapeutic Areas
The investigator's research portfolio includes studies on atopic dermatitis, chronic spontaneous urticaria, and non-responsive celiac disease.
- Immune-mediated disorders
- Novel therapeutic applications
- Long-term treatment outcomes
Their work explores innovative treatment approaches for these challenging conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.